This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations in Lung Cancer Treatment by Run-Ze Li
Introduction
Run-Ze Li is an accomplished inventor based in Macau, CN. He has made significant contributions to the field of medical science, particularly in the treatment of lung cancer. His innovative approach has the potential to improve the lives of many patients suffering from this disease.
Latest Patents
Run-Ze Li holds a patent for a method of treating lung cancer. This invention involves administering a therapeutically effective amount of a compound with the formula 0089-0022 to a subject in need. The compound activates the pyruvate kinase M2 isoform (PKM2), which is crucial in the treatment of lung cancer. Notably, this method is applicable to Non-Small Cell Lung Cancer (NSCLC), a common and aggressive form of lung cancer. He has 1 patent to his name.
Career Highlights
Run-Ze Li is affiliated with the Macau University of Science and Technology, where he conducts research and develops innovative solutions in the medical field. His work is characterized by a commitment to advancing cancer treatment methodologies.
Collaborations
He collaborates with esteemed colleagues, including Lai-Han Elaine Leung and Xiao-Jun Yao, to further enhance the research and development of effective cancer treatments.
Conclusion
Run-Ze Li's contributions to lung cancer treatment exemplify the impact of innovative research in medicine. His work not only advances scientific knowledge but also offers hope to patients battling this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile